Segments - Single-use Bioprocessing Probes and Sensors Market by Sensor Type (Flow Meters & Sensors, pH Sensors, Temperature Sensors, Oxygen Sensors, Pressure Sensors, Conductivity Sensors, and Others), Workflow Outlook (Downstream and Upstream), End-user (Academic & Research Institutes, Biopharmaceuticals & Pharmaceutical Companies, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global single-use bioprocessing probes and sensors market size was valued at USD 2.52 Billion in 2023 and is likely to reach USD 7.18 Billion by 2031, expanding at a CAGR of 12.02% during 2023–2031. The growth of the market is attributed to increasing demand for the single-use and advanced bioprocessing probes and sensors.
Increasing prevalence of chronic disorders is resulting in the high demand for single-use bioprocessing probes and sensors. They help to monitor timely and accurately temperature levels, pH, and dissolved oxygen. These probes and sensors are disposable, which reduces the risk of cross-contaminating. Moreover, the growing number of people dying due the chronic disorders, thus propelling the market.
According to the report published by the World Health Organization (WHO) on September 16, 2023, states that non-communicable diseases (NCDs) are responsible for 74% of global deaths, which is approximately 41 million fatalities per year. Among these, cardiovascular diseases account for the highest number of deaths, which is about 17.9 million lives, followed by cancers with 9.3 million, chronic respiratory diseases with 4.1 million, and diabetes with 2 million fatalities.
Single-use bioprocessing probes and sensors are specialized instruments designed for monitoring and controlling various parameters during the production of biopharmaceuticals, vaccines, and other biological products. Unlike traditional sensors, single-use bioprocessing sensors are used once and disposed of after use. They are important in ensuring the quality and safety of these products. Additionally, these sensors are highly efficient and reduce the time and effort required for validation and maintenance.
The reports state that the COVID-19 pandemic boosted the market. The demand for these sensors surged due to the rapid development and production of vaccines, therapeutics, and diagnostic tests in response to the pandemic. The urgency to meet global healthcare needs has increased reliance on single-use sensors, as they offer efficiency and sterility benefits.
Emergence of artificial intelligence is expected to propel the market. AI-driven data analytics and real-time monitoring help in fine-tuning bioprocessing parameters, ensuring precision and quality during production. This contributes to the consistent and efficient manufacturing of these probes and sensors. Additionally, AI aids in predictive maintenance, identifying sensor issues or malfunctions before they cause problems, which reduces downtime and maintenance costs.
Rising adoption of disposable systems during the early, preclinical phases of bioprocessing is expected to drive the market. These disposable systems include sensors and probes. They are cost-effective and save a lot of time and effort as compared to cleaning and maintaining traditional equipment.
Furthermore, major players of the medical devices sensors and probes manufacturing industry are expanding their production facilities to cater to the growing demand, which further boosts the market.
On February 15, 2022, Thermo Fisher Scientific Inc, a global supplier of medical technology, announced plans to invest USD 40 million in the expansion of its single-use manufacturing facility in Millersburg. This expansion is expected to increase its capacity to provide the technology and materials needed for the development of new treatments and vaccines in the biopharma industry. The Millersburg facility is able to significantly contribute to the production of medical technology.
Environmental concerns associated with the use of single-use probes and sensors are expected to hinder the market. Single-use systems generate plastic waste due to their disposable nature. While they reduce the need for extensive cleaning, they contribute to environmental issues related to plastic waste management. These factors are reducing the adoption of and the demand for single use probes and sensors.
Continuous development of biodegradable or sustainable materials for single-use sensors is expected to create favorable opportunities for the players competing in the market. These materials are biodegradable or eco-friendly thus, reducing the environmental impact of disposable systems. Furthermore, manufacturers are integrating of Internet of Things (IoT) technology in sensors allowing remote monitoring, which further fuels the market.
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Single-use Bioprocessing Probes and Sensors Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Sensor Type (Flow Meters & Sensors, pH Sensors, Temperature Sensors, Oxygen Sensors, Pressure Sensors, Conductivity Sensors, and Others), Workflow Outlook (Downstream and Upstream), and End-user (Academic & Research Institutes, Biopharmaceuticals & Pharmaceutical Companies, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Dover Corporation; Hamilton Company; PARKER HANNIFIN CORP; PendoTECH; PharmNXTBiotech; PreSens Precision Sensing GmbH; Saint-Gobain; Sartorius AG; and Thermo Fisher Scientific Inc |
Based on sensor type, the single-use bioprocessing probes and sensors market is divided into flow meters & sensors, pH sensors, temperature sensors, oxygen sensors, pressure sensors, conductivity sensors, and others. The pH segment is expected to hold a major market revenue share during the forecast period, as they are widely utilized in maintaining the right pH level, especially in the production of biopharmaceuticals.
pH sensors are essential for ensuring that these processes remain within the desired range, ultimately affecting the quality and efficiency of product development. Moreover, ongoing technological developments in pH sensors, including built-in temperate monitoring further boost the segment.
The oxygen sensor segment is anticipated to register robust growth during the forecast period owing to the rising number of adults suffering with chronic conditions. Oxygen sensors help monitor oxygen and ensure that the optimal concentration is maintained in the body.
For instance, according to the report published by the National Association of Chronic Disease Directors in 2022, approximately 60% of the adults in the US are suffering from chronic disorders.
Oxygen sensors are highly optimized during cell culture and fermentation processes to real-time monitoring and control of oxygen. These all factors contribute to propel the segment.
In terms of workflow outlook, the market is fragmented into downstream and upstream. The upstream segment is expected to hold a key market share during the projected period, as in upstream phase, cells are cultivated and prepared for product generation.
Monitoring factors, including pH, temperature, and oxygen levels, are crucial for ensuring the health and optimal growth of these cells. Sensors important for providing real-time data for immediate adjustments and maintaining the ideal conditions.
The downstream segment is projected to register a considerable CAGR during the forecast period due to the massive utilization of sensors and probes in downstream enabling precise control and monitoring of separation processes. This control leads to the optimization of product yield, reducing wastage and lowering production costs.
Moreover, as bioprocessing techniques and biopharmaceuticals become complex and advanced the demand for sensors in downstream processing is growing and propelling the market.
Based on end-user, the market is divided into academic & research institutes, biopharmaceuticals & pharmaceutical companies, and others. The biopharmaceuticals & pharmaceutical companies segment is expected to hold a key share of the market during the projected period, as single-use sensors and probes are used to ensure the quality, safety, and efficiency of these biopharmaceutical processes.
Additionally, the growing demand for pharmaceuticals is boosting utilization of disposable sensors and probes in this companies. The academic & research institutes segment is expected to expand at a significant CAGR during the forecast period owing to the rising scientific exploration and development activities.
Single-use sensors are fundamental tools in these settings, facilitating experimentation, data collection, and process optimization. Moreover, diverse applications of disposable sensors and probes across various research areas boost their demand.
In terms of region, the global single-use bioprocessing probes and sensors market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market due to the well-established biopharmaceutical industry.
This industry relies heavily on bioprocessing technologies and sensors for the production of vaccines, monoclonal antibodies, and other biopharmaceutical products. The presence of numerous established companies in this sector is fueling the market.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years due to the rapidly growing biopharmaceutical industry. Factors such as presence of a large and aging population, rising healthcare expenditure, and increasing burden of chronic diseases are driving the demand for biopharmaceuticals. This surge in biopharmaceutical production necessitates efficient and reliable sensors for monitoring and controlling bioprocessing operations.
The global single-use bioprocessing probes and sensors market has been segmented on the basis of
Key players competing in the global single-use bioprocessing probes and sensors market are Dover Corporation; Hamilton Company; PARKER HANNIFIN CORP; PendoTECH; PharmNXTBiotech; PreSens Precision Sensing GmbH; Saint-Gobain; Sartorius AG; and Thermo Fisher Scientific Inc.
These companies are boosting their market share by adopting various strategies such as partnerships, mergers, reduction in production costs, launching products, and implementing advanced technologies.